Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN
Phase 3
Recruiting
- Conditions
- Chemotherapy-induced Polyneuropathy
- Interventions
- Drug: PlaceboDrug: Aconite pain oil
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- WALA Heilmittel GmbH
- Target Recruit Count
- 350
- Registration Number
- NCT06186479
- Locations
- 🇩🇪
Medizinische Fakultät Mannheim der Uniklinik Heidelberg, Mannheim, Germany
© Copyright 2025. All Rights Reserved by MedPath